Annette Fisseler-Eckhoff

Author PubWeight™ 25.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy. Lung Cancer 2009 1.68
2 Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma. Eur J Cardiothorac Surg 2012 1.42
3 Borderline tumors of the ovary: clinical course and prognostic factors. Onkologie 2012 1.42
4 Proficiency testing of immunohistochemical biomarker assays in breast cancer. Virchows Arch 2008 1.38
5 NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res 2008 1.02
6 Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification. Virchows Arch 2012 1.01
7 The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc 2014 1.00
8 Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria. J Thorac Oncol 2014 0.98
9 Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids. Virchows Arch 2013 0.98
10 Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing. Lung Cancer 2013 0.97
11 Endoscopic findings in patients with Schatzki rings: evidence for an association with eosinophilic esophagitis. World J Gastroenterol 2012 0.95
12 Differences in the receptor status between primary and recurrent breast cancer--the frequency of and the reasons for discordance. Oncology 2013 0.89
13 Changes in the topological expression of markers of differentiation and apoptosis in defined stages of human cervical dysplasia and carcinoma. Gynecol Oncol 2003 0.87
14 BRCA1 germline mutation in a woman with metaplastic squamous cell breast cancer. Onkologie 2007 0.86
15 Analysis of KRAS Mutations of Exon 2 Codons 12 and 13 by SNaPshot Analysis in Comparison to Common DNA Sequencing. Gastroenterol Res Pract 2010 0.86
16 Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma. Gynecol Oncol 2010 0.85
17 Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus. Mod Pathol 2008 0.84
18 Prognostic risk factors of early esophageal adenocarcinomas. Ann Surg 2014 0.82
19 Synchronous ovarian and endometrial cancer--an international multicenter case-control study. Int J Gynecol Cancer 2014 0.81
20 Expression of extracellular matrix-proteins in perisellar connective tissue and dura mater. Acta Neurochir (Wien) 2009 0.80
21 Outcome of early breast cancer treated in an urban and a rural breast cancer unit in Germany. Onkologie 2013 0.80
22 Requirements to assess feasibility of phase 0 trials during major abdominal surgery: variability of PARP activity. Clin Cancer Res 2012 0.79
23 Signature of microsatellite instability, KRAS and BRAF gene mutations in German patients with locally advanced rectal adenocarcinoma before and after neoadjuvant 5-FU radiochemotherapy. J Gastrointest Oncol 2013 0.79
24 Atypical lipomatous tumor in a 14-year-old patient: distinction from lipoblastoma using FISH analysis. Virchows Arch 2002 0.79
25 The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma. Thorac Cardiovasc Surg 2011 0.78
26 Short- and long-term outcome of sleeve resections in the elderly. Eur J Cardiothorac Surg 2009 0.77
27 Assessment of the sentinel lymph node in patients with invasive squamous carcinoma of the vulva. Acta Obstet Gynecol Scand 2009 0.77
28 Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections. Lung Cancer 2013 0.76
29 pT2 Adenocarcinoma of the esophagus: early or advanced cancer? Ann Thorac Surg 2013 0.75
30 [Molecular diagnostics and imaging]. Onkologie 2009 0.75